Publication | Closed Access

Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)

Surgical OncologyMedicineCancer ManagementCisplatin RegimensGynecologySurgerySurgical End-stagingOvarian CarcinomaCancer TreatmentOncologyGynecology OncologyOvarian Cancer